EryDel

Healthcare

HQ: Urbino, Italy

Investors: 3

A late-stage biotechnology company specialized in drug delivery through red blood cells for the treatment of rare neurodegenerative diseases.

Investors (3)

Fund	Status	Entry Date	Stage	Source
Andera Partners	Exited	-	-	-
Origine SGR	Exited	-	-	-
Sofinnova Partners	Exited	-	-	Website

Get these signals delivered weekly

Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.